ArticleClinical lung cancer2024

Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations.

Matthew S Lara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.